HIV vaccine: Historic trial begins
HIV vaccine: Historic trial begins
- The HVTN 702 trial will enrol 5 400 HIV-negative men and women at 15 research sites across South Africa, of which three will be in Gauteng.
- The HVTN 702 trial will enrol 5 400 HIV-negative men and women at 15 research sites across South Africa, of which three will be in Gauteng.